Dobutamine for Spinal Cord Injury

(CARDIO-SCI Trial)

CW
LA
Overseen ByLucero Aceves, PhD
Age: 18+
Sex: Any
Trial Phase: Phase < 1
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The first hours-to-day following acute traumatic cervical SCI represent a critical period of time to optimize hemodynamic management. After a spinal cord injury, cardiovascular function is affected. Maintaining blood pressure becomes is an important part of treatment as it supports recovery of the injured spinal cord. Blood pressure is most often increased using vasopressors, such as norepinephrine. Although these drugs help maintain blood flow, they may also lead to increased bleeding in the injury site, making the lesion worse. Alternatively, dobutamine, a medication that helps the heart pump more effectively, has shown to maintain blood pressure and improve prefusion at the injury site. This study will assess dobutamine capacity to maintain blood pressure acutely post injury.

Are You a Good Fit for This Trial?

This trial is for people who have recently suffered a spinal cord injury in the neck or upper back area. Participants must be in the early hours to days after their injury and need help managing their blood pressure.

Inclusion Criteria

Able to communicate in English and provide informed consent
I have a recent spinal cord injury between C0 and T1, classified as AIS A or B.

Exclusion Criteria

I have been diagnosed with aortic stenosis.
Pregnant
I had a heart attack within the last 2 days.
See 7 more

What Are the Treatments Tested in This Trial?

Interventions

  • Dobutamine

Trial Overview

The study tests dobutamine, a medication that helps the heart pump better, to see if it can safely maintain blood pressure right after spinal cord injury. Patients will receive dobutamine and possibly other standard treatments in a crossover design.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Dobutamine CrossoverExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+